nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE1C—brain—conduct disorder	0.0376	0.0829	CbGeAlD
Dipyridamole—PRUNE—brain—conduct disorder	0.034	0.0748	CbGeAlD
Dipyridamole—PDE6D—brain—conduct disorder	0.0328	0.0722	CbGeAlD
Dipyridamole—PDE6B—brain—conduct disorder	0.0323	0.071	CbGeAlD
Dipyridamole—PDE6H—brain—conduct disorder	0.03	0.066	CbGeAlD
Dipyridamole—PDE11A—brain—conduct disorder	0.03	0.066	CbGeAlD
Dipyridamole—PDE7A—brain—conduct disorder	0.0267	0.0589	CbGeAlD
Dipyridamole—PDE7B—brain—conduct disorder	0.0234	0.0514	CbGeAlD
Dipyridamole—PDE8A—G alpha (s) signalling events—CGA—conduct disorder	0.0226	0.0413	CbGpPWpGaD
Dipyridamole—PDE8B—G alpha (s) signalling events—CGA—conduct disorder	0.0226	0.0413	CbGpPWpGaD
Dipyridamole—PDE2A—G alpha (s) signalling events—CGA—conduct disorder	0.022	0.0403	CbGpPWpGaD
Dipyridamole—PDE7B—G alpha (s) signalling events—CGA—conduct disorder	0.0201	0.0369	CbGpPWpGaD
Dipyridamole—PDE10A—brain—conduct disorder	0.0195	0.0429	CbGeAlD
Dipyridamole—PDE2A—brain—conduct disorder	0.0195	0.0429	CbGeAlD
Dipyridamole—PDE1B—brain—conduct disorder	0.0193	0.0425	CbGeAlD
Dipyridamole—PDE11A—G alpha (s) signalling events—CGA—conduct disorder	0.0187	0.0343	CbGpPWpGaD
Dipyridamole—PDE7A—G alpha (s) signalling events—CGA—conduct disorder	0.0187	0.0343	CbGpPWpGaD
Dipyridamole—PDE8B—brain—conduct disorder	0.0186	0.041	CbGeAlD
Dipyridamole—PDE3B—brain—conduct disorder	0.0182	0.04	CbGeAlD
Dipyridamole—PDE8A—brain—conduct disorder	0.0167	0.0368	CbGeAlD
Dipyridamole—PDE10A—G alpha (s) signalling events—CGA—conduct disorder	0.0167	0.0305	CbGpPWpGaD
Dipyridamole—PDE1A—brain—conduct disorder	0.0162	0.0357	CbGeAlD
Dipyridamole—ADA—brain—conduct disorder	0.0138	0.0303	CbGeAlD
Dipyridamole—PDE4A—brain—conduct disorder	0.0134	0.0295	CbGeAlD
Dipyridamole—PDE5A—brain—conduct disorder	0.0114	0.0251	CbGeAlD
Dipyridamole—PDE3A—brain—conduct disorder	0.0111	0.0244	CbGeAlD
Dipyridamole—PDE3B—G alpha (s) signalling events—CGA—conduct disorder	0.0108	0.0198	CbGpPWpGaD
Dipyridamole—ABCC5—brain—conduct disorder	0.0104	0.023	CbGeAlD
Dipyridamole—PDE4A—G alpha (s) signalling events—CGA—conduct disorder	0.0101	0.0185	CbGpPWpGaD
Dipyridamole—PDE3A—G alpha (s) signalling events—CGA—conduct disorder	0.00982	0.018	CbGpPWpGaD
Dipyridamole—SLC29A1—brain—conduct disorder	0.00958	0.0211	CbGeAlD
Dipyridamole—PDE1A—G alpha (s) signalling events—CGA—conduct disorder	0.00924	0.0169	CbGpPWpGaD
Dipyridamole—PDE1B—G alpha (s) signalling events—CGA—conduct disorder	0.00845	0.0155	CbGpPWpGaD
Dipyridamole—ABCC4—brain—conduct disorder	0.00723	0.0159	CbGeAlD
Dipyridamole—PDE1C—Innate Immune System—MB21D1—conduct disorder	0.00657	0.012	CbGpPWpGaD
Dipyridamole—ADA—Circadian rythm related genes—SLC6A4—conduct disorder	0.00514	0.00943	CbGpPWpGaD
Dipyridamole—ADA—Circadian rythm related genes—DRD4—conduct disorder	0.00484	0.00886	CbGpPWpGaD
Dipyridamole—ABCC5—NRF2 pathway—SLC6A4—conduct disorder	0.00483	0.00884	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—POLR3A—conduct disorder	0.00482	0.00884	CbGpPWpGaD
Dipyridamole—ADA—Validated transcriptional targets of TAp63 isoforms—EP300—conduct disorder	0.00479	0.00877	CbGpPWpGaD
Dipyridamole—PDE8B—GPCR downstream signaling—CGA—conduct disorder	0.00463	0.00848	CbGpPWpGaD
Dipyridamole—PDE8A—GPCR downstream signaling—CGA—conduct disorder	0.00463	0.00848	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—CGA—conduct disorder	0.00451	0.00827	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—CGA—conduct disorder	0.00421	0.0077	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—CGA—conduct disorder	0.00421	0.0077	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—CGA—conduct disorder	0.00413	0.00756	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—CGA—conduct disorder	0.0041	0.00751	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—WASF1—conduct disorder	0.00406	0.00744	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—CGA—conduct disorder	0.00384	0.00703	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—CGA—conduct disorder	0.00384	0.00703	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—MB21D1—conduct disorder	0.00383	0.00701	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—CGA—conduct disorder	0.00375	0.00687	CbGpPWpGaD
Dipyridamole—SLC29A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00368	0.00673	CbGpPWpGaD
Dipyridamole—ADA—p73 transcription factor network—EP300—conduct disorder	0.00353	0.00647	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—MB21D1—conduct disorder	0.0035	0.00642	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—CGA—conduct disorder	0.00348	0.00638	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—CGA—conduct disorder	0.00348	0.00638	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—CGA—conduct disorder	0.00342	0.00627	CbGpPWpGaD
Dipyridamole—ADA—C-MYB transcription factor network—EP300—conduct disorder	0.00336	0.00616	CbGpPWpGaD
Dipyridamole—ABCC4—NRF2 pathway—SLC6A4—conduct disorder	0.00335	0.00613	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—CGA—conduct disorder	0.00323	0.00592	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—MB21D1—conduct disorder	0.0032	0.00587	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—CGA—conduct disorder	0.00311	0.00569	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—CGA—conduct disorder	0.00292	0.00535	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—CGA—conduct disorder	0.00292	0.00535	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—POLR3A—conduct disorder	0.00281	0.00515	CbGpPWpGaD
Dipyridamole—PDE8B—GPCR downstream signaling—DRD4—conduct disorder	0.00259	0.00475	CbGpPWpGaD
Dipyridamole—PDE8A—GPCR downstream signaling—DRD4—conduct disorder	0.00259	0.00475	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—POLR3A—conduct disorder	0.00257	0.00471	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—DRD4—conduct disorder	0.00253	0.00463	CbGpPWpGaD
Dipyridamole—ABCB1—brain—conduct disorder	0.00252	0.00554	CbGeAlD
Dipyridamole—PDE8B—Signaling Pathways—CGA—conduct disorder	0.00248	0.00455	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CGA—conduct disorder	0.00248	0.00455	CbGpPWpGaD
Dipyridamole—ABCC5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00243	0.00446	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling by Wnt—EP300—conduct disorder	0.00242	0.00444	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling by Wnt—EP300—conduct disorder	0.00242	0.00444	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CGA—conduct disorder	0.00242	0.00444	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—WASF1—conduct disorder	0.00237	0.00433	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—DRD4—conduct disorder	0.00235	0.00431	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—DRD4—conduct disorder	0.00235	0.00431	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—POLR3A—conduct disorder	0.00235	0.00431	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—WASF1—conduct disorder	0.00234	0.00429	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—WASF1—conduct disorder	0.00234	0.00429	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—DRD4—conduct disorder	0.00231	0.00423	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—DRD4—conduct disorder	0.00229	0.0042	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CGA—conduct disorder	0.00221	0.00406	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—CGA—conduct disorder	0.00221	0.00405	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—WASF1—conduct disorder	0.00216	0.00396	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—DRD4—conduct disorder	0.00215	0.00394	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—DRD4—conduct disorder	0.00215	0.00394	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—DRD4—conduct disorder	0.0021	0.00385	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—CGA—conduct disorder	0.00207	0.0038	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CGA—conduct disorder	0.00206	0.00377	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CGA—conduct disorder	0.00206	0.00377	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—MB21D1—conduct disorder	0.00204	0.00374	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—CGA—conduct disorder	0.00202	0.00369	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—CGA—conduct disorder	0.00201	0.00368	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—WASF1—conduct disorder	0.00199	0.00365	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—WASF1—conduct disorder	0.00199	0.00365	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—WASF1—conduct disorder	0.00198	0.00363	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—DRD4—conduct disorder	0.00195	0.00357	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—DRD4—conduct disorder	0.00195	0.00357	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—WASF1—conduct disorder	0.00194	0.00355	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—DRD4—conduct disorder	0.00192	0.00351	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CGA—conduct disorder	0.00191	0.0035	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—CGA—conduct disorder	0.0019	0.00347	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CGA—conduct disorder	0.00188	0.00345	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—CGA—conduct disorder	0.00188	0.00345	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MB21D1—conduct disorder	0.00187	0.00342	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CGA—conduct disorder	0.00183	0.00336	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CGA—conduct disorder	0.00183	0.00335	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—DRD4—conduct disorder	0.00181	0.00331	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—WASF1—conduct disorder	0.00177	0.00325	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—DRD4—conduct disorder	0.00174	0.00319	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CGA—conduct disorder	0.00173	0.00318	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CGA—conduct disorder	0.00172	0.00315	CbGpPWpGaD
Dipyridamole—PDE8A—GPCR downstream signaling—HTR2A—conduct disorder	0.00169	0.0031	CbGpPWpGaD
Dipyridamole—PDE8B—GPCR downstream signaling—HTR2A—conduct disorder	0.00169	0.0031	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00169	0.00309	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—CGA—conduct disorder	0.00167	0.00307	CbGpPWpGaD
Dipyridamole—ADA—Circadian rythm related genes—EP300—conduct disorder	0.00167	0.00306	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—WASF1—conduct disorder	0.00165	0.00302	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—WASF1—conduct disorder	0.00165	0.00302	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—HTR2A—conduct disorder	0.00165	0.00302	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—DRD4—conduct disorder	0.00164	0.003	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—DRD4—conduct disorder	0.00164	0.003	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CGA—conduct disorder	0.00157	0.00288	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling by Wnt—EP300—conduct disorder	0.00156	0.00286	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—HTR2A—conduct disorder	0.00154	0.00281	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—HTR2A—conduct disorder	0.00154	0.00281	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—WASF1—conduct disorder	0.00153	0.0028	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—WASF1—conduct disorder	0.00151	0.00276	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—HTR2A—conduct disorder	0.00151	0.00276	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—HTR2A—conduct disorder	0.0015	0.00274	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—POLR3A—conduct disorder	0.0015	0.00274	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—WASF1—conduct disorder	0.00147	0.00269	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—HTR2A—conduct disorder	0.0014	0.00257	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—HTR2A—conduct disorder	0.0014	0.00257	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—DRD4—conduct disorder	0.00139	0.00255	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—DRD4—conduct disorder	0.00139	0.00255	CbGpPWpGaD
Dipyridamole—PDE2A—Hemostasis—EP300—conduct disorder	0.00138	0.00253	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—HTR2A—conduct disorder	0.00137	0.00251	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—POLR3A—conduct disorder	0.00137	0.00251	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—DRD4—conduct disorder	0.00136	0.00248	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—HTR2A—conduct disorder	0.00127	0.00233	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—HTR2A—conduct disorder	0.00127	0.00233	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—WASF1—conduct disorder	0.00126	0.00231	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—HTR2A—conduct disorder	0.00125	0.00229	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—DRD4—conduct disorder	0.00124	0.00227	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—DRD4—conduct disorder	0.00124	0.00227	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—CGA—conduct disorder	0.00122	0.00223	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CGA—conduct disorder	0.00119	0.00217	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—HTR2A—conduct disorder	0.00118	0.00216	CbGpPWpGaD
Dipyridamole—PDE11A—Hemostasis—EP300—conduct disorder	0.00118	0.00215	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—DRD4—conduct disorder	0.00116	0.00213	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—DRD4—conduct disorder	0.00115	0.00211	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—DRD4—conduct disorder	0.00115	0.00211	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—WASF1—conduct disorder	0.00115	0.00211	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—HTR2A—conduct disorder	0.00113	0.00208	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—DRD4—conduct disorder	0.00113	0.00207	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—DRD4—conduct disorder	0.00113	0.00206	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CGA—conduct disorder	0.00111	0.00204	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CGA—conduct disorder	0.00108	0.00198	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—DRD4—conduct disorder	0.00107	0.00196	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—HTR2A—conduct disorder	0.00107	0.00196	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—HTR2A—conduct disorder	0.00107	0.00196	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—DRD4—conduct disorder	0.00106	0.00194	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—DRD4—conduct disorder	0.00105	0.00193	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—DRD4—conduct disorder	0.00105	0.00193	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—EP300—conduct disorder	0.00105	0.00192	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—EP300—conduct disorder	0.00105	0.00192	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—DRD4—conduct disorder	0.00103	0.00188	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—DRD4—conduct disorder	0.00103	0.00188	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CGA—conduct disorder	0.00102	0.00186	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—EP300—conduct disorder	0.000981	0.0018	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—DRD4—conduct disorder	0.000971	0.00178	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—DRD4—conduct disorder	0.000964	0.00177	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—WASF1—conduct disorder	0.000951	0.00174	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CGA—conduct disorder	0.00093	0.0017	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—HTR2A—conduct disorder	0.000908	0.00166	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—HTR2A—conduct disorder	0.000908	0.00166	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—WASF1—conduct disorder	0.000891	0.00163	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—HTR2A—conduct disorder	0.000885	0.00162	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—DRD4—conduct disorder	0.000881	0.00161	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—WASF1—conduct disorder	0.000867	0.00159	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—WASF1—conduct disorder	0.000815	0.00149	CbGpPWpGaD
Dipyridamole—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000814	0.00149	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—HTR2A—conduct disorder	0.000809	0.00148	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—HTR2A—conduct disorder	0.000809	0.00148	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—EP300—conduct disorder	0.000808	0.00148	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—EP300—conduct disorder	0.000808	0.00148	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—HTR2A—conduct disorder	0.000757	0.00139	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—COMT—conduct disorder	0.000755	0.00138	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—HTR2A—conduct disorder	0.000752	0.00138	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—HTR2A—conduct disorder	0.000752	0.00138	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—MAOA—conduct disorder	0.00075	0.00137	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—WASF1—conduct disorder	0.000745	0.00137	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—HTR2A—conduct disorder	0.000736	0.00135	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—HTR2A—conduct disorder	0.000734	0.00135	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—HTR2A—conduct disorder	0.000697	0.00128	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—HTR2A—conduct disorder	0.000692	0.00127	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—HTR2A—conduct disorder	0.000688	0.00126	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—HTR2A—conduct disorder	0.000687	0.00126	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—EP300—conduct disorder	0.000678	0.00124	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HTR2A—conduct disorder	0.00067	0.00123	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000669	0.00123	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—HTR2A—conduct disorder	0.000669	0.00123	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—DRD4—conduct disorder	0.000665	0.00122	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—HTR2A—conduct disorder	0.000633	0.00116	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—HTR2A—conduct disorder	0.000629	0.00115	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—DRD4—conduct disorder	0.000622	0.00114	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—EP300—conduct disorder	0.000617	0.00113	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—DRD4—conduct disorder	0.000606	0.00111	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—EP300—conduct disorder	0.00058	0.00106	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—HTR2A—conduct disorder	0.000575	0.00105	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—EP300—conduct disorder	0.000571	0.00105	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—DRD4—conduct disorder	0.000569	0.00104	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—EP300—conduct disorder	0.000566	0.00104	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—EP300—conduct disorder	0.000566	0.00104	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—COMT—conduct disorder	0.000549	0.00101	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—MAOA—conduct disorder	0.000545	0.000998	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—EP300—conduct disorder	0.000531	0.000973	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—EP300—conduct disorder	0.000528	0.000966	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—EP300—conduct disorder	0.000523	0.000957	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—DRD4—conduct disorder	0.000521	0.000954	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—EP300—conduct disorder	0.00052	0.000953	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—EP300—conduct disorder	0.000481	0.000881	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—EP300—conduct disorder	0.000481	0.000881	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—EP300—conduct disorder	0.000478	0.000876	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—EP300—conduct disorder	0.000469	0.000859	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HTR2A—conduct disorder	0.000434	0.000795	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—EP300—conduct disorder	0.000429	0.000785	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HTR2A—conduct disorder	0.000406	0.000744	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—EP300—conduct disorder	0.000402	0.000737	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—EP300—conduct disorder	0.000398	0.00073	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—EP300—conduct disorder	0.000398	0.00073	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HTR2A—conduct disorder	0.000395	0.000724	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HTR2A—conduct disorder	0.000371	0.000681	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EP300—conduct disorder	0.000369	0.000677	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EP300—conduct disorder	0.000364	0.000668	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EP300—conduct disorder	0.000355	0.000651	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000348	0.000637	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HTR2A—conduct disorder	0.00034	0.000622	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CGA—conduct disorder	0.000334	0.000612	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—EP300—conduct disorder	0.000324	0.000593	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EP300—conduct disorder	0.000304	0.000558	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EP300—conduct disorder	0.000281	0.000515	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EP300—conduct disorder	0.000281	0.000515	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EP300—conduct disorder	0.000278	0.00051	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EP300—conduct disorder	0.000257	0.000471	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—EP300—conduct disorder	0.000235	0.000431	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EP300—conduct disorder	0.00023	0.000421	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EP300—conduct disorder	0.000215	0.000394	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EP300—conduct disorder	0.000209	0.000383	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EP300—conduct disorder	0.000197	0.000361	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EP300—conduct disorder	0.00018	0.00033	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—COMT—conduct disorder	0.000151	0.000276	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MAOA—conduct disorder	0.00015	0.000274	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—EP300—conduct disorder	6.47e-05	0.000118	CbGpPWpGaD
